Trial Profile
A Phase I Study of Perifosine + Capecitabine for Patients With Advanced Colon Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Jul 2018
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Perifosine (Primary)
- Indications Colon cancer
- Focus Adverse reactions
- Sponsors AEterna Zentaris Inc
- 27 Feb 2013 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 17 Oct 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
- 17 Oct 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.